COMMENTARY

Better Diabetes Self-Management With Cognitive Therapy

Peter M. Yellowlees, MBBS, MD

Disclosures

June 20, 2014

This feature requires the newest version of Flash. You can download it here.

This is the Medscape Psychiatry Minute. I'm Dr. Peter Yellowlees.

We know that diabetic control of patients who are depressed and have diabetes is improved if their depression is treated. Now a team of investigators[1] from Massachusetts General Hospital in Boston have performed a randomized controlled trial to test cognitive-behavioral therapy (CBT) for adherence and depression in 87 adults with unipolar depression and uncontrolled type 2 diabetes.

The control patients received treatment as usual, including medication adherence, self-monitoring of blood glucose, and lifestyle counseling, whereas those assigned to the intervention arm also received 9-11 sessions of CBT focused on adherence and depression. Analyses of 4-, 8-, and 12-month follow-up time points indicated that the intervention group maintained 24% higher medication adherence, 17% greater adherence to self-monitoring of blood glucose, and lower A1c values, with both groups being less depressed.

The researchers concluded that CBT has enduring and clinically meaningful benefits for diabetes self-management and glycemic control in adults with type 2 diabetes and depression. This is yet more evidence in support of the effectiveness of CBT in many areas of medicine and reminds us of their importance in clinical practice.

This article is selected from Medscape Best Evidence. I'm Dr. Peter Yellowlees.

Abstract

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....